Wang Bryan

Title: Innovations of Inventor Wang Bryan

Introduction

Wang Bryan is an accomplished inventor based in Wyomissing, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of peptides that target the epidermal growth factor receptor (EGFR) on tumor cells. With a total of 2 patents, his work has the potential to impact drug delivery systems and cancer treatment.

Latest Patents

Wang Bryan's latest patents include "EGFR binding peptides and uses thereof" and "Dimeric high affinity EGFR constructs and uses thereof." The first patent provides short oligopeptides capable of binding to the EGFR on human tumor cells. It also outlines methods for using these peptides as targeting moieties in more complex compositions, such as conjugates of cytotoxins and liposomal structures for drug delivery. The second patent focuses on polypeptides comprising EGFR extracellular domains I-III, which can form dimeric EGF-binding proteins. This dimeric construct is useful in applications requiring high-affinity EGF binding and can be employed to select agents that bind to native EGFR in the presence of EGF.

Career Highlights

Throughout his career, Wang Bryan has worked with notable companies such as Centocor, Inc. and Janssen Biotech, Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.

Collaborations

Wang Bryan has collaborated with talented individuals, including Frank Shi and Mohit Trikha. These partnerships have likely enhanced his research and innovation efforts.

Conclusion

Wang Bryan is a notable inventor whose work in developing EGFR-targeting peptides has the potential to advance cancer treatment and drug delivery systems. His contributions to biotechnology are significant and reflect his dedication to innovation in the field.